Recurrent deletions of a~600-kb region of 16p11.2 have been associated with a highly penetrant form of childhood apraxia of speech (CAS). Yet prior findings have been based on a small, potentially biased sample using retrospectively collected data. We examine the prevalence of CAS in a larger cohort of individuals with 16p11.2 deletion using a prospectively designed assessment battery. The broader speech and language phenotype associated with carrying this deletion was also examined. 55 participants with 16p11.2 deletion (47 children, 8 adults) underwent deep phenotyping to test for the presence of CAS and other speech and language diagnoses. Standardized tests of oral motor functioning, speech production, language, and non-verbal IQ were conducted. The majority of children (77%) and half of adults (50%) met criteria for CAS. Other speech outcomes were observed including articulation or phonological errors (i.e., phonetic and cognitive-linguistic errors, respectively), dysarthria (i.e., neuromuscular speech disorder), minimal verbal output, and even typical speech in some. Receptive and expressive language impairment was present in 73% and 70% of children, respectively. Co-occurring neurodevelopmental conditions (e.g., autism) and non-verbal IQ did not correlate with the presence of CAS. Findings indicate that CAS is highly prevalent in children with 16p11.2 deletion with symptoms persisting into adulthood for many. Yet CAS occurs in the context of a broader speech and language profile and other neurobehavioral deficits. Further research will elucidate specific genetic and neural pathways leading to speech and language deficits in individuals with 16p11.2 deletions, resulting in more targeted speech therapies addressing etiological pathways.
Introduction
A recurrent~600-kb heterozygous deletion of 16p11.2, at approximate position~29. 6-30.2 Mb in the reference genome (GRCh37/hg19), is widely acknowledged to affect speech and language development in individuals who carry it [1] [2] [3] [4] . Up to 70% of affected individuals present with some form of communication disorder [5] . Yet there is a paucity of evidence delineating the specific types of speech and/or language disorders associated with the deletion, limiting precise definition of the communication phenotype.
Specificity of phenotyping is important given that childhood apraxia of speech (CAS), a complex diagnosis, has been identified as a core communication deficit in children with the canonical 16p11.2 deletion [2,`6-8] . CAS is a severe motor speech disorder affecting the precision and consistency of speech production [9] . The only study to systematically assess speech in children with 16p11.2 deletion found all nine verbal participants had CAS [2] . These findings are of considerable interest given that the prevalence of CAS in the general population is estimated at only 0.01-0.02% [10] . However, the study was limited by a small and potentially biased sample and the use of retrospectively collected data [2] . Further work is thus required across a larger sample and using prospective assessments carefully designed to conduct differential diagnosis of communication disorder.
At a broader level of communication phenotyping, beyond CAS, even the simple differentiation between speech and language impairments in individuals with 16p11.2 deletion has received little focus [11] , with some studies conflating the two. Yet speech production [12, 13] is supported by cognitive and neural mechanisms distinct from those that support higher-level language processing [2] . Similarly, there has been a lack of differentiation of expressive versus receptive language abilities, although both are seemingly affected [6, 14, 15] . Moreover, no study has examined performance in specific language subdomains (e.g., semantics, syntax, phonology). Limited evidence is also available for the related outcome of literacy, with reading and writing often examined in case reports [1, 8] rather than larger cohorts [5] . Finally, given that language outcomes have often been described in cases selected for the presence of autism spectrum disorder (ASD), deep speech and language phenotyping in a sample unselected for neurodevelopmental conditions is needed to better understand the specificity and prevalence of communication deficits across the more general population of children with 16p11.2 deletion. The use of specific diagnoses reached by valid methods is essential for clinical management, as these distinct categories necessitate disorder-specific interventions.
Our aims were threefold: (1) Examine the prevalence of CAS in a large unselected cohort of individuals with 16p11.2 deletion, using a prospectively determined assessment battery; (2) Characterize specific co-occurring speech production and language diagnoses to provide a comprehensive study of the communication phenotype; and (3) Examine the relationship between CAS and other behaviors of language, oral motor function, non-verbal cognition, as well as the presence of neurodevelopmental conditions (e.g., epilepsy and/or seizures, autism) in an attempt to better understand the underlying cognitive architecture associated with 16p11.2 deletions.
Subjects and methods

Participants
Eligibility criteria for probands included a diagnosis of 16p11.2 recurrent microdeletion (~600-kb including DOC2A and TBX6) and an age between 2;11 and 18;0 years. Affected siblings and parents of the proband were also eligible. Participants were excluded if they demonstrated an additional copy-number variant, a neurological condition impacting speech, or had taken part in our previously published work [2] .
Participants were recruited from two sources: Victorian Clinical Genetics Services (VCGS, Australia) and the 2015 Simons Variation in Individuals Project (VIP) Connect Family Meeting (Washington, US). For the US sample, the study was advertised to families attending the Simons VIP Meeting. Families within Australia were identified via the VCGS database. Probands on the database who met study eligibility (as described above) were contacted. The Human Research Ethics Committees at The Royal Children's Hospital, Melbourne (#27053), and the Massachusetts Institute of Technology (#1306005763) approved the study.
Measures
Participants completed a range of face-to-face clinical measures, as described below. The battery took~2-2.5 h to administer. The number of participants contributing to each measure is available as supplemental material. Demographic data (e.g., hearing, vision, gross, and fine motor) were obtained from parents and the Simons VIP.
Aim 1: Prevalence of CAS, and Aim 2: Broader speech and language phenotype speech production (including CAS) Differential diagnosis of speech occurred across: articulation disorder (deficit at the phonetic, motoric level of speech, e.g., phonetic distortions such as a lisp or being unable to produce a particular sound); [16] phonological disorder (deficit at the phonemic level reflecting cognitivelinguistic errors e.g., a sound can be produced but is used in incorrect contexts or word positions); [17] dysarthria (impaired neuromuscular execution of speech associated with disruption of tone and/or incoordination of movements, e.g., speech may sound "slurred"); [18] and CAS (impaired planning and programming of speech impacting on precision and consistency, e.g., difficulty initiating and sequencing speech, within speech groping or searching for the correct placement of the tongue and lips) [9, 18] .
Articulation deficits were evaluated using the GoldmanFristoe Test of Articulation-2 (GFTA-2) [19] . GFTA-2 responses were analyzed for phonological processes and compared to normative data [20] to identify disordered, delayed or age appropriate processes (see supplemental material Table S1 for definitions). This distinction is essential given that disordered phonology (compared to delayed) is associated with persistent speech difficulties and impaired phonological awareness and literacy [21, 22] . Dysarthria was diagnosed based on (1) the presence of oromotor dysfunction (i.e., impaired Focal Oromotor Control based on speech and non-speech tasks, as described below) signaling impaired neuromuscular tone or coordination of movements; and (2) concomitant deviant perceptual speech features rated during a 10-min conversational speech sample, affecting articulation, resonance, prosody, respiration, and/or phonation.
For CAS, diagnostic criteria were adapted from Murray et al. [23, 24] based on three American Speech and Hearing Association consensus-based criteria [9] , as in our previous work [2] : (1) inconsistent production of the same word; (2) lengthened and disrupted coarticulatory transitions; and 3) prosodic errors (see Table 1 ). The same criteria were used for child and adult participants given the absence of diagnostic criteria for adults with CAS. Inconsistent production was examined using the standardized Inconsistency subtest of the Diagnostic Evaluation of Articulation and Phonology (DEAP) [20] . Prosodic, syllable and sound sequencing errors typifying disrupted co-articulatory transitions were analyzed using the Single-Word Test of Polysyllables [24, 25] . Overall speech accuracy ratings of Percent Consonants Correct (PCC) and Percent Vowels Correct (PVC) were also derived from this tool. Where this test could not be completed (n = 8), speech accuracy ratings were calculated using the GFTA-2. PCC scores were categorized by severity: mild (>85), mild-moderate (65-85), moderatesevere (50-64), and severe (<50) [26] . The 10-minute conversational speech sample was also analyzed to identify further features of CAS (see Table 1 ) [2, 24, 25] .
Oral motor function
Oral motor function was assessed in children aged ≥3 years using the Verbal Motor Production Assessment for Children (VMPAC) [27] , the most psychometrically robust oral motor assessment available for children [28] . Three scales were administered: Global Motor Control, a measure of neuromotor innervation to peripheral muscles in the torso, neck, head and face; Focal Oromotor Control assessing control of the jaw, lips, face and tongue during speech and non-speech tasks; and Sequencing, examining performance of oral and speech movements in sequential order. Children <3 years were evaluated using the Oral and Speech Motor Control Protocol (OSMCP) [29] . The DEAP Oromotor subtest [20] , which includes tasks examining isolated and sequenced non-speech movements, was used for two children unable to complete the VMPAC due to reduced attention. Oromotor abilities of adults (>18 years) were measured using the Frenchay Dysarthria Assessment-2 (FDA-2) [30] . These tools assess both speech and nonspeech oral motor tasks.
Language & literacy
Australian participants <21 years were evaluated with the Clinical Evaluation of Language Fundamentals (CELFPreschool 2 or CELF-4, depending on age) [31, 32] . The CELF Core Language Score, reflecting overall receptive and expressive language competence, was used to identify impaired language. Children ≤3 years were assessed using the Preschool Language Scale-5 (PLS-5) [33] , a measure of receptive and expressive language. Due to time constraints, language functioning of the US child cohort (n = 5) was measured using the CELF-5 Recalling Sentences subtest [34] . Deficits in receptive and expressive language were recorded based on the CELF Core Language subtests, with impairments in specific subdomains (i.e., semantics, syntax, morphology) further identified. For those who completed the PLS-5, deficits were based on participants' overall scores (Auditory Comprehension and Expressive Communication) and the Profile form. Auditory short-term memory was also examined in the Australian cohort aged >5 years (n = 26) using the Forwards Number Repetition subtest of the CELF-4.
Seven of 8 adults were examined using the Peabody Picture Vocabulary Test-4 (PPVT-4) [35] , a measure of receptive vocabulary, and the Test for Reception of Grammar-2 (TROG-2) [36] , a measure of grammatical comprehension. The Nonword Repetition subtest of the Comprehensive Test of Phonological Processing-2 (CTOPP-2) [37] was completed by children (n = 29) and adults (n = 7) as an indicator of phonological processing and awareness, early precursors of literacy. Literacy outcomes of the Australian cohort (n = 26) were measured using the Word Reading and Spelling subtests of the Wide Range Achievement Test-4 (WRAT-4) [38] .
Aim 3: Associations between CAS and other neurologic cognitive-behavioral domains
Information regarding additional diagnoses (e.g., epilepsy, autism, attention deficit hyperactivity disorder (ADHD), gross and fine motor impairment) was obtained from parents and the Simons VIP. Non-verbal cognition was measured with the Wechsler Abbreviated Scale of Intelligence-2 (WASI-2) [39] for participants >6 years (n = 38) or Kaufman Brief Intelligence Test-2 (K-BIT-2) [40] for those <6 years (n = 2).
Analysis
Results for the Australian and US cohorts were combined given that demographic characteristics were comparable ( Table 2) . Where different measures were used across children, scores from measures examining similar constructs were grouped where possible (e.g., CELF-4, PLS-5). For Aim 1, CAS ratings were completed by CM. A second speech pathologist (AM), who was blinded to CAS status, also completed ratings for n = 15,~30% of the sample, to confirm CAS diagnoses. For Aim 2, data were transcribed and analyzed, and standard scores were computed for all relevant tests by CM to provide a differential diagnosis of speech, language, and literacy.
For Aim 3, the relationship between CAS and children's broader phenotype (e.g., autism, ADHD, epilepsy and/or seizures, non-speech oromotor) was examined using the Fisher's exact test. The Mann-Whitney U t-test was used to compare the language, auditory short-term memory and non-verbal IQ scores of children with and without CAS. The association between CAS and speech-related oromotor impairment was examined using the Spearman's rank correlation. This test was also used to investigate the correlation between language and non-verbal IQ.
Results
Altogether, 55 participants were recruited: 47 Australian (40 children, 7 adults) and 8 American (7 children, 1 adult). Sample characteristics are detailed in Table 2 . Age of participants ranged from 2;11 to 17;9 years for probands (n = 44) and child siblings (n = 3) and 20;4 to 48;2 years for the remaining affected adult siblings (n = 1) and parents (n = 7). Of the child sample, 51% (24/47) were currently receiving speech and/or language therapy while 38% (18/ 47) had received this type of therapy in the past.
As not all participants completed each assessment (due to factors such as age, time constraints, compliance), the denominators presented below vary. Denominators used reflect the number of participants who completed each assessment, as detailed in the supplemental material (Table S2 ).
Aim 1: Prevalence of CAS, and Aim 2: Broader speech and language phenotype speech production Three child participants were excluded from speech analyses due to minimal verbal output (n = 2) or missing data (n = 1). Of remaining participants, 89% (39/44) had impaired speech (Fig. 1) . Children demonstrated a range of PCC severity ratings: mild (51%, 22/43), mild-moderate (33%, 14/43), moderate-severe (9%, 4/43), and severe (2%, 1/43). PCC data were not available for one child.
Diagnostic criteria for CAS were met by 77% (34/44) of children (Table 1) . Only 29% (10/34) of this sample had previously received a clinical diagnosis of CAS. Whilst CAS was prevalent, articulation and phonological speech errors were also common, present in 43% (19/44) and 82% (36/44) of children, respectively. Of the 19 children with articulation errors (e.g., interdental or lateral fricatives, labiodental production of bilabials), 11 had structural deficits likely to be causing the phonetic distortion (e.g., malocclusion, submucous cleft palate, misaligned teeth). Phonological processes were classified as delayed in 36% (16/44) and disordered in 45% of children (20/44) (supplemental material Table S3 ).
For children, CAS occurred in conjunction with both articulation and phonological errors (23%, 10/44), phonological errors alone (34%, 15/44), articulation errors alone (5%, 2/44) or dysarthria with co-occurring articulation and/ or phonological errors (16%, 7/44). Five of the ten children without a CAS diagnosis had other forms of speech impairment; isolated phonological (n = 2) or articulation errors (n = 1), and co-occurrence of these errors (n = 2).
For the adult cases, 50% (4/8) met the CAS diagnostic criteria (Table 1) . Three adults presented with articulation errors (i.e., interdental fricatives) and/or phonological processes involving 'th' (i.e., stopping, fronting), respectively used by 25% (2/8) of adults (one demonstrated co-occurring articulation and phonological errors). The remaining five cases showed no errors during less demanding speech tasks (e.g., conversation, GFTA-2), but produced one or more errors (e.g., metathesis, epenthesis, assimilation) during more complex tasks such as producing polysyllables. PCC speech severity ratings were mild in all impaired adult cases (71%, 5/7).
Oromotor
In the Australian child cohort, oromotor functioning was impaired in 85% (28/33). Oromotor functioning was not assessed in 14 children. Thirty children completed the Global Motor Control scale of the VMPAC, with performance classified as within normal limits for 27% (8/30), moderately impaired for 23% (7/30), and severely impaired for 50% (15/30) . Within this scale, impairments were often characterized by reductions in tongue strength (53%, 16/ 30), soft palate contraction (47%, 14/30) and smoothness or range of movement (33%, 10/30).
The Focal Oromotor Control scale, was completed by 29 children with impaired functioning seen in 76% (22/29). Severity of impairment was classified as mild (7%, 2/29), moderate (10%, 3/29), or severe (59%, 17/29). Poor performance during single non-speech oromotor movements reflected impaired lingual movements (48%, 14/29; e.g., reduced tongue elevation and lateralization), labial-facial movements (31%, 9/29; e.g., poor lip rounding and, in two cases, asymmetry), and mandibular control (10%, 3/29; e.g., reduced jaw excursion and stability). Impaired double nonspeech oromotor movements (e.g., "smile and kiss") were common (45%, 13/29), typified by impaired transition and precision of movements. With regard to speech-related oromotor movements, deficits were frequently noted during the production of triple oromotor sequences (e.g., /a-m-u/; 72%, 21/29) and words/sentences (e.g., "bow, toe, go"; 74%, 20/27). In comparison, impaired single (e.g., /a/) and double speech movements (e.g., /a-u/) were seen in 55% (16/29) and 45% (13/29), respectively. Twenty-nine children completed the Sequencing scale. Performance on this scale revealed the greatest difficulty, with severe impairment noted in 79% (23/29) of children. Mild and moderate impairments were infrequent (14%, 4/29, and 7%, 2/29) as were intact sequencing skills (14%, 4/29). Sequencing deficits were seen across all tasks (i.e., sequencing of non-speech oromotor movements, phonemes, and words).
Oromotor functioning was assessed in 6 of the 8 adults, with all showing some degree of impaired laryngeal and tongue control (during speech and/or non-speech tasks). Common features included reductions in phonation time, volume control, and non-speech and speech tongue movements (elevation and alternating sequences). Palatal and lip deficits were also common, both occurring in 67% (4/6) of adults. These deficits reflected poor palatal movement h Normative mean = 10 (SD 3). Scores greater than 1 SD below the normative mean were classified as impaired except for non-verbal IQ, which was classified as: high average (110-119), average (90-109), low average (80-89), borderline (70-79) and extremely low (<70). b US cohort not included as they only completed the Recalling Sentences subtest. Language was unable to be assessed in 7 of the Australian children due to reasons such as the cooperation of the child, profound language difficulties, or the absence of a recent language assessment for children whose data were obtained from clinical reports. c Cognitive testing not possible for 14 children (due to the child's age or capabilities) and 1 adult.
d Measured using the CELF-4, CELF-P2 or PLS-5. e 1 child completed the PPVT-4, a measure of receptive vocabulary, as they were unable to complete the CELF-4 due to severe speech and language impairment. f Measured using the CELF-4 Number Repetition-Forwards subtest (Australian cohort only).
g Not completed by 5 children who were unable to complete the sample items. during phonation and reduced alternating lip movements during speech. Reflexes (e.g., cough, swallow) and intelligibility were relatively spared (both areas impaired in 1/6 cases). Reduced respiratory support for speech was observed in two adults although this was associated with a chest infection.
Language, cognition & literacy
For the child cases, language was not evaluated in seven due to poor child compliance (n = 4), severity of verbal impairment (n = 1), or missing data (n = 2). Of those assessed, 83% (33/40) had a language impairment, with Core Language Scores (i.e., overall receptive-expressive abilities) greater than two standard deviations below the normative mean (Table 3) . Language impairment in children commonly affected both expressive and receptive abilities (60%, 24/40) rather than only expressive (5%, 2/ 40) or only receptive (3%, 1/40) abilities. Differences in expressive and receptive language were not examined in 6 children as only one or the other domain was evaluated due to severe expressive language difficulties (n = 2), selective mutism (n = 1), or time constraints (n = 3). Impairments were present across the subdomains of semantics, syntax, and morphology (Table 3) . Non-verbal IQ and literacy scores for children were greater than one standard deviation below the normative mean (Table 3) . Auditory short-term memory (measured using the CELF-4) and phonological memory (based on the CTOPP-2) were respectively impaired in 80% (20/25) and 94% (32/34) of children (Table 3) .
For the adults, 86% (6/7) had impaired language, with performance on the PPVT-4 and TROG-2 greater than one standard deviation below the mean (Table 3) . Language was not assessed with one adult. Non-verbal IQ and literacy scores for this group were two standard deviations below the normative mean (Table 3) .
Aim 3: Associations between CAS and other neurologic cognitive-behavioral domains
Results from the Fisher's exact test did not identify an association between CAS status in the children and autism (p = 0.15), ADHD (p = > 0.999), gross or fine motor function (p = 0.27, and p = 0.70, respectively), epilepsy and/or seizures (p = 0.47), Similarly, the Mann-Whitney U t-test did not reveal an association between CAS and language (U = 64, p = 0.12) and non-verbal IQ (U = 69, p = 0.15), although CAS was associated with poor short-term auditory memory (U = 21, p = 0.01).
The association between CAS and non-speech oromotor function in children, measured by the Fisher's exact test, was not statistically significant (p = 0.55 for mandibular control, p = 0.37 for labial-facial control, and p = 0.39 for tongue function). Similarly, results from the Spearman's rank test revealed that Focal Oromotor Control percentage scores (i.e., speech and non-speech oromotor performance) were not correlated with GFTA-2 standard scores for children with CAS (r = 0.13, p = 0.58). This pattern suggests that articulation was not associated with oromotor performance for this group. Performance on the Sequencing scale was related to DEAP Inconsistency scores (r = −0.93, p = < 0.001) but not GFTA-2 scores (r = 0.26, p = 0.26) for children with CAS, indicating that children with poorer sequencing abilities (during speech and non-speech tasks) produced a higher number of inconsistent speech errors.
Children's language scores (reflecting overall receptive and expressive language competence) were not correlated with non-verbal IQ (r = −0.08, p = 0.73), even when children with hearing impairment were excluded (r = −0.04, p = 0.86). Notably, the language abilities of 6 children were ≥2 standard deviations below their non-verbal IQ.
Discussion
In line with our previous work [2] , we found that CAS is prevalent (77%) in individuals with canonical 16p11.2 deletions. Further, our findings suggest that speech and/or language disorder is more common than previously estimated in this population, with 98% of children demonstrating some form of speech or language impairment and a significant proportion (57%) having co-occurrence of these deficits. Other neurobehavioural conditions (e.g., epilepsy and/or seizures, autism) were not correlated with a diagnosis of CAS.
Although most children (89%) demonstrated impaired speech, severity ratings were mild or mild-moderate for the majority of the cohort (i.e., PCC ratings >65), and only two cases were minimally verbal. Interestingly, only 29% of children with CAS had previously received a clinical diagnosis of CAS (despite all previously having seen a SLP), suggesting potential misdiagnosis in the clinical community and, consequently, lack of targeted intervention of motor planning and programming deficits, as needed for improving these children's outcomes. This result is not surprising considering the variable criteria used by clinicians for the diagnosis of CAS [41] . Our findings highlight the need for clinicians to systematically test for the presence of CAS based on the ASHA consensus criteria in children with 16p11.2 deletion to improve management of speech in this population. Further, our data show that CAS commonly occurs with other speech disorders (dysarthria, articulation, and phonological), hence a careful differential diagnosis is required and clinical problem solving needed to therapeutically target the specific level(s) of deficit. In addition to managing surface behaviors, health professionals may consider referring children with CAS for clinical genetic testing if indicated to determine potential underlying causes such as 16p11.2 deletion.
In relation to language, a fairly consistent profile was demonstrated in that deficits involved both receptive and expressive language. This is in line with previous reports where a mixed receptive-expressive language impairment profile has been associated with 16p11.2 deletion [6, 14, 15] . Here, however, we highlight that the language deficit is not restricted to a particular subdomain, rather it is generalized affecting morphology, syntax and semantics. This finding is shared by other syndromes associated with intellectual disability (e.g., Floating Harbour and Kabuki) [42, 43] . Our findings further refine the phenotype associated with 16p11.2 deletion by revealing that it is not linked to a syndrome-specific language profile where only specific subdomains are affected.
Although it is probable that children's broader cognitive profile is related to their language attainment given their shared genetic bases [44] mean language scores were nearly one standard deviation below non-verbal IQ. In contrast, children's literacy outcomes, as measured by the WRAT-4, were a relative strength and more commensurate with average non-verbal IQ performance. This differs from previous research where strengths in literacy were not as apparent in comparison to language [5] . For instance, in Hanson et al. [5] word reading abilities were, on average, just below verbal IQ (76 and 79, respectively) whereas here, a greater split between word reading and language abilities was apparent (83 and 69, respectively). This difference could potentially be due to differences in measures or sample characteristics (e.g., in Hanson et al. [5] 46% had language impairment whereas here it occurred in 83% of children).
With regard to adults, all had mild speech severity ratings and typically only issues during more demanding speech motor tasks (e.g., polysyllabic words). Notably, the diagnostic criteria for CAS were met by 50% of adults with the remaining cases showing some symptoms despite not meeting the pre-defined criteria for a formal diagnosis. Importantly, the phenotype of CAS differed between adults and children, consistent with the broader CAS literature [45] . Specifically, children demonstrated features such as syllable segregation and voicing errors that were not seen in adults. Although CAS is recognized as a persistent speech disorder, how it evolves during adulthood remains poorly understood, including for individuals with 16p11.2 deletions. The cross-sectional design of the current study makes it difficult to infer the progression of speech disorders for this population, necessitating the need for future large scale prospectively designed longitudinal studies.
In terms of associated factors, CAS occurred independent of other neurobehavioural conditions, such as autism, ADHD, and epilepsy and/or seizures in children. Nonverbal IQ was also not predictive of CAS. These results should be interpreted with some caution however, given the limitations of our study (e.g., small sample size and the wide age range of participants, which may have impacted on analyses that included neurodevelopmental conditions that are not typically diagnosed in early infancy e.g., ADHD). Our finding of an association between CAS and memory deficits is consistent with prior reports [46] . Speech (articulation and phonology) and language outcomes could have been impacted by hearing impairment (conductive), which occurred in 19% of the child sample. This is particularly plausible for speech outcomes as all children with impaired hearing had a speech deficit, typically articulation and/or phonological errors that occurred in the presence of CAS. A limitation of our data is that hearing status was obtained via parent-report, potentially under-representing the occurrence of hearing impairment in this cohort.
It is most probable that CAS observed in people with 16p11.2 deletions is associated with specific neural and genetic markers yet to be explored in this population. While the speech phenotype associated with 16p11.2 deletion is largely expressed as CAS, the following profiles may be seen: (i) typical speech-sound development, (ii) isolated developmental articulation disorder or phonological delay, (iii) CAS with or without dysarthria, articulation or phonological errors, or even (iv) non-verbal presentation. Of interest would be to determine the combination of genetic and neural markers that can predict children's speech outcome. Although language impairment has been linked to the number of genomic copies of the 16p11.2 region [47] and abnormal development of neural pathways supporting language function (i.e., left arcuate fasciculus) in cases with 16p11.2 deletion [48] , the mechanisms underlying speech dysfunction for this group remain unknown.
Future research may also examine whether more severe phenotypes observed in individuals with 16p11.2 deletion (e.g., non-verbal presentations) are associated with the 'twohit' model suggested by Girirajan et al. [49] This model proposes that severe phenotypes linked to 16p12.2 microdeletions result from a secondary insult (e.g., an additional copy number variant, gene mutation or environmental factor). The model has been applied to children with 16p11.2 deletion [50] but it has yet to be determined how relevant it is for explaining speech outcomes.
Whilst we aimed to recruit a sample less biased than previous reports [2] and unselected for neurodevelopmental conditions (e.g., ASD), our cohort may have been biased towards children with developmental concerns due to our method of recruitment (i.e., a genetics service where individuals are often referred due to specific clinical indications). In addition, it is possible that being advertised as a speech and language study, our sample could be biased towards individuals with speech and language conditions. We, however, aimed to mitigate this by indicating that all individuals, even those without speech and language disorders, were eligible.
This study is the largest to date to systematically assess speech and language skills in children with 16p11.2 deletion. We confirm that CAS is a core component of the speech phenotype seen in children with 16p11.2 deletion. A potential extension of this work is to compare the phenotype against intra-familial controls and 16p11.2 duplication cases. Future research should be directed at examining causal pathways in order to identify the specific genetic and neural mechanisms underpinning CAS. This will provide much needed data informing the etiology of CAS given that only a small proportion of cases can currently be explained by known genetic mutations (e.g., FOXP2 and GRIN2A) [51] .
